Paul L. Berns

Companies

• Kardigan, Inc.Board member Jun 18, 2026 to now¹
• Neumora Therapeutics, Inc.Officer Feb 18, 2025 to now²
• Metsera, Inc.Board member Jan 30, 2025 to now³
• Neumora Therapeutics, Inc.Board member Sep 14, 2023 to now⁴
• Unity Biotechnology, Inc.Board member May 2, 2018 to now⁵
• EQRx, Inc.Board member Dec 20, 2021 to Nov 9, 2023⁶
• Jazz PharmaceuticalsBoard member Jun 8, 2010 to Aug 9, 2021⁷
• Yarrow Bioscience, Inc.Board member Jan 24, 2018 to Aug 8, 2019⁸
• Cellectar Biosciences, Inc.Board member Aug 18, 2014 to Apr 21, 2016⁹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• KKardigan, Inc. KARD15,062,741 shares¹⁰$195.5M at $12.98Jun 24, 2026
• NTNeumora Therapeutics, Inc. NMRA7,528,282 shares¹¹$3.6M at $0.47Feb 19, 2026
• EEQRx, Inc.0 shares¹²Nov 9, 2023
• MMetsera, Inc.0 shares¹³Nov 13, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

• Jun 22, 2026Bought 1,250,000 shares at $16.00 of Kardigan, Inc.¹⁰
• Jun 17, 2026Granted 20,706 shares of Kardigan, Inc.¹⁴
• Jun 17, 2026Converted 13,792,035 shares of Kardigan, Inc.¹⁴
• Mar 6, 2026Bought 488,090 shares at $25.61 of Lyell Immunopharma, Inc.¹⁵
• Feb 17, 2026Sold 9,819 shares at $3.51 of Neumora Therapeutics, Inc.¹¹
• Nov 13, 2025Returned to company 957,559 shares of Metsera, Inc.¹³
• Nov 13, 2025Returned to company 8,313,680 shares of Metsera, Inc.¹³
• Nov 13, 2025Returned to company 7,523,682 shares of Metsera, Inc.¹³
• Nov 13, 2025Returned to company 4,031 shares of Metsera, Inc.¹³
• Feb 18, 2025Sold 13,871 shares at $1.69 of Neumora Therapeutics, Inc.¹⁶
• Feb 3, 2025Bought 789,998 shares at $18.00 of Metsera, Inc.¹⁷
• Feb 3, 2025Converted 7,523,682 shares of Metsera, Inc.¹⁷
• Dec 27, 2024Gift 133,097 shares of Neumora Therapeutics, Inc.¹⁸
• Dec 27, 2024Gift 133,097 shares of Neumora Therapeutics, Inc.¹⁸
• Dec 27, 2024Gift 133,097 shares of Neumora Therapeutics, Inc.¹⁸
• Feb 14, 2024Granted 171,250 shares of Neumora Therapeutics, Inc.¹⁹
• Nov 9, 2023Returned to company 627,000 shares of EQRx, Inc.¹²
• Dec 17, 2021Granted 627,000 shares of EQRx, Inc.²⁰